Table 2

Parameters of fasciculation potentials (FPs) in the three groups of subjects studied, expressed as mean values and SD's

G1–61 patients TA muscle—MRC 5/5G2—12 patients TA muscle—MRC 4/5G3—10 patients Benign FPsp Value
Number of FPs2237661
Amplitude (μV)719.26±596.44 range 131–35991115.17±656.2 range 249–3250506.85±307.67 range 117–1440*G1 vs G2—p<0.001 *G1 vs G3—p=0.029 *G2 vs G3—p<0.001
Duration (ms)13.25±5.11 range 2.8–37.416.0±4.00 range 6.4–2611.77±4.47 range 3.1–22*G1 vs G2—p<0.001 *G1 vs G3—p=0.082 *G2 vs G3—p<0.001
Number of phases3.63±1.73 range 2–154.37±1.91 range 2–112.98±1.04 range 1–6†G1 vs G2—p<0.001 †G1 vs G3—p=0.007 †G2 vs G3—p<0.001
Polyphasic (%)18.4735.534.9‡G1 vs G2—p<0.018 ‡G1 vs G3—p=0.021 ‡G2 vs G3—p<0.001
Doublets (%)2.711.80‡G1 vs G2—p<0.001 ‡G1 vs G3—p=0.240 ‡G2 vs G3—p<0.001
  • *The data in the three groups was compared using the one-way analysis of variance (ANOVA) test. As a post hoc test for differences between pairs of groups we used the Tukey test.

  • †The data in the three groups was compared using the Kruskal-Wallis test. As a post hoc test for differences between pairs of groups we used the Mann-Whitney test.

  • ‡The data in the three groups was compared using the contingency tables.

  • ALS, amyotrophic lateral sclerosis; G1, group 1 (ALS patients with tibialis anterior strength=5 on the medical research council (MRC) scale); G2, group 2 (ALS patients with tibialis anterior strength=4 on the MRC scale); G3, group 3 (patients with benign fasciculations); TA, tibialis anterior.